May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Roberto Ferrara: Time to tailor chemo-IO in early stage NSCLC
Apr 14, 2025, 07:18

Roberto Ferrara: Time to tailor chemo-IO in early stage NSCLC

Roberto Ferrara, Medical Oncologist,Researcher in Thoracic Oncology and Molecular Immunology at Vita-Salute San Raffaele University, posted on LinkedIn:

“Time to tailor chemo-IO in early stage NSCLC. Reconstructed individual patient data analysis shows NEOAD= PERIOP in pCR, MPR and no-MPR. PERIOP performs well in pure-MPR (1-10% RVT). While pCR or no-MPR may deserve future descalation or escalation treatment strategies, respectively.”

Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysis

Authors: Antonio Nuccio et al.

Roberto Ferrara: Time to tailor chemo-IO in early stage NSCLC